Sign in

CIK 0001267565

  • Large accelerated filer

COLLEGIUM PHARMACEUTICAL, INC

Sign in to watch
Ticker
COLL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
Phone
+1 781-713-3699
Business address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
Former names
COLLEGIUM PHARMACEUTICAL INC
  1. 4 Open-market sale EVP and General Counsel sold 7,000 shares at $22.77 ($159,390)
  2. 4 Shares withheld for taxes EVP and Chief Medical Officer gave up 3,119 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP & Chief Technical Officer gave up 9,657 shares (to pay taxes)
  4. 4 Grant or award Chief Technical Officer acquired 5,984 shares (grant or award)
  5. 4 Shares withheld for taxes EVP and General Counsel gave up 734 shares (to pay taxes)
  6. 4 Open-market sale Director sold 50,075 shares at an average $25.30 ($1,266,774)
  7. 4 Open-market sale President and CEO sold 64,768 shares at an average $22.67 ($1,468,425)
  8. 4 Open-market sale Chief Technical Officer sold 18,235 shares at an average $22.60 ($412,169)
  9. 4 Open-market sale EVP & Chief Commercial Officer sold 7,898 shares at an average $25.21 ($199,132)
  10. 4 Shares withheld for taxes EVP and General Counsel gave up 5,858 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Technical Officer gave up 7,144 shares (to pay taxes)
  12. 4 Shares withheld for taxes President and CEO gave up 23,786 shares (to pay taxes)
  13. 4 Shares withheld for taxes Executive Vice President & CFO gave up 8,491 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP and Chief Medical Officer gave up 2,300 shares (to pay taxes)
  15. 4/A Grant or award President and CEO acquired 133,989 shares (grant or award)
  16. 4/A Grant or award Chief Technology Officer acquired 51,889 shares (grant or award)
  17. 4/A Grant or award EVP & Chief Commercial Officer acquired 51,945 shares (grant or award)
  18. 4/A Grant or award Executive Vice President & CFO acquired 50,161 shares (grant or award)
  19. 4/A Open-market sale EVP and General Counsel sold 6,081 shares at $24.45 ($148,680)
  20. 4/A Grant or award EVP and Chief Medical Officer acquired 39,147 shares (grant or award)

Page 9 of 21 · 415 filings